Biosynex SA (FR:ALBIO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Biosynex SA, a leader in health diagnostics, reported a turnover of €93 million in 2023 and has expanded its international presence with subsidiaries in the US, Europe, and Asia. Specializing in rapid tests and molecular biology, the company offers a range of diagnostic and care solutions for both professionals and the general public. With over 500 employees and operations in 95 countries, Biosynex is listed on Euronext Growth Paris and continues to innovate in the field of rapid diagnostics.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.